﻿<?xml version="1.0" encoding="utf-8"?>
<rss xmlns:itunes="http://www.itunes.com/dtds/podcast-1.0.dtd" xmlns:atom="http://www.w3.org/2005/Atom" version="2.0">
  <channel>
    <ttl>60</ttl>
    <title>Bayer Investor Events</title>
    <description><![CDATA[
		Podcasts of all Bayer investor events
		]]></description>
    <atom:link href="http://www.podcast.bayer.com/module/podcast/investor.xml" rel="self" type="application/rss+xml" />
    <link>http://www.podcast.bayer.com</link>
    <lastBuildDate>Thu, 25 Apr 2013 11:00:00 GMT</lastBuildDate>
    <image>
      <url>http://www.podcast.bayer.com/img/bayer-kreuz.gif</url>
      <title>Bayer Investor Events</title>
      <link>http://www.podcast.bayer.com</link>
    </image>
    <language>en-US</language>
    <copyright>Bayer AG, Leverkusen, Germany</copyright>
    <managingEditor>bayermaildesk@bayermail.com (Bayer AG, Leverkusen, Germany)</managingEditor>
    <webMaster>bayermaildesk@bayermail.com (Bayer AG, Leverkusen, Germany)</webMaster>
    <category>Business</category>
    <itunes:subtitle>Bayer Investor Events</itunes:subtitle>
    <itunes:author>Bayer AG, Leverkusen, Germany</itunes:author>
    <itunes:summary><![CDATA[
		Speeches from News and Investor Conferences, Annual Stockholders' Meetings and further Events of the Bayer Group
		]]></itunes:summary>
    <itunes:owner>
      <itunes:name>Bayer AG, Leverkusen, Germany</itunes:name>
      <itunes:email>bayermaildesk@bayermail.com</itunes:email>
    </itunes:owner>
    <itunes:image href="http://www.podcast.bayer.com/img/bayer-kreuz.gif" />
    <itunes:category text="Business">
      <itunes:category text="Business News" />
    </itunes:category>
    <itunes:keywords>News, Business, Pharma, Chemical, Nutrition, Drugmaker, Health, Industry, Science, Technology, Research, Innovation</itunes:keywords>
    <itunes:explicit>clean</itunes:explicit>
    <item>
      <title>April 25, 2013, Q1 2013 Investor Conference Call</title>
      <link>http://www.webvideo.bayer.com/downloads/9202/9206/12343/q1-2013-investor-conference-call.mp3</link>
      <description><![CDATA[Dr. Marijn Dekkers, CEO of Bayer AG, on the Q1 2013 Investor Conference Call. Followed by a discussion.]]></description>
      <pubDate>Thu, 25 Apr 2013 11:00:00 GMT</pubDate>
      <author>bayermaildesk@bayermail.com (Bayer AG, Leverkusen, Germany)</author>
      <guid>http://www.webvideo.bayer.com/downloads/9202/9206/12343/q1-2013-investor-conference-call.mp3</guid>
      <category>Business</category>
      <enclosure url="http://www.webvideo.bayer.com/downloads/9202/9206/12343/q1-2013-investor-conference-call.mp3" length="25025976" type="audio/mpeg" />
      <itunes:author>Bayer AG, Leverkusen, Germany</itunes:author>
      <itunes:subtitle><![CDATA[]]></itunes:subtitle>
      <itunes:summary><![CDATA[Dr. Marijn Dekkers, CEO of Bayer AG, on the Q1 2013 Investor Conference Call. Followed by a discussion.]]></itunes:summary>
      <itunes:duration>69:30</itunes:duration>
      <itunes:image href="http://www.webvideo.bayer.com" />
      <itunes:keywords>Pharmacy, Research, Innovation, HealthCare, MaterialScience, CropScience, Quarterly results, Financials</itunes:keywords>
    </item>
    <item>
      <title>March 19, 2013, Meet Management 2013 in Leverkusen</title>
      <link>http://www.webvideo.bayer.com/downloads/9202/9206/12324/Meet_Management_2012-03-19_Leverkusen_Audio.mp3</link>
      <description><![CDATA[Presentation by Dr. Marijn Dekkers, CEO of Bayer AG, at the Meet Management 2013 Bayer Investor Day in Leverkusen]]></description>
      <pubDate>Tue, 19 Mar 2013 11:00:00 GMT</pubDate>
      <author>bayermaildesk@bayermail.com (Bayer AG, Leverkusen, Germany)</author>
      <guid>http://www.webvideo.bayer.com/downloads/9202/9206/12324/Meet_Management_2012-03-19_Leverkusen_Audio.mp3</guid>
      <category>Business</category>
      <enclosure url="http://www.webvideo.bayer.com/downloads/9202/9206/12324/Meet_Management_2012-03-19_Leverkusen_Audio.mp3" length="6496760" type="audio/mpeg" />
      <itunes:author>Bayer AG, Leverkusen, Germany</itunes:author>
      <itunes:subtitle><![CDATA[]]></itunes:subtitle>
      <itunes:summary><![CDATA[Presentation by Dr. Marijn Dekkers, CEO of Bayer AG, at the Meet Management 2013 Bayer Investor Day in Leverkusen]]></itunes:summary>
      <itunes:duration>18:21</itunes:duration>
      <itunes:image href="http://www.webvideo.bayer.com" />
      <itunes:keywords>Chemistry, Pharmacy, Research, Innovation, HealthCare, MaterialScience, CropScience</itunes:keywords>
    </item>
    <item>
      <title>February 28, 2013, FY/Q4 2012 Investor Conference Call</title>
      <link>http://www.webvideo.bayer.com/downloads/9202/9206/12313/file.mp3</link>
      <description><![CDATA[Dr. Marijn Dekkers, CEO of Bayer AG, at the FY/Q4 2012 Investor Conference Call. Followed by a discussion.]]></description>
      <pubDate>Thu, 28 Feb 2013 11:00:00 GMT</pubDate>
      <author>bayermaildesk@bayermail.com (Bayer AG, Leverkusen, Germany)</author>
      <guid>http://www.webvideo.bayer.com/downloads/9202/9206/12313/file.mp3</guid>
      <category>Business</category>
      <enclosure url="http://www.webvideo.bayer.com/downloads/9202/9206/12313/file.mp3" length="37497417" type="audio/mpeg" />
      <itunes:author>Bayer AG, Leverkusen, Germany</itunes:author>
      <itunes:subtitle><![CDATA[]]></itunes:subtitle>
      <itunes:summary><![CDATA[Dr. Marijn Dekkers, CEO of Bayer AG, at the FY/Q4 2012 Investor Conference Call. Followed by a discussion.]]></itunes:summary>
      <itunes:duration>78:07</itunes:duration>
      <itunes:image href="http://www.webvideo.bayer.com" />
      <itunes:keywords>Annual Report, Chemistry, Pharmacy, Research, Innovation, HealthCare, MaterialScience, CropScience</itunes:keywords>
    </item>
    <item>
      <title>Meet Management 2012 in Tokyo - Summary; Presentation by Dr. Marijn Dekkers</title>
      <link>http://www.webvideo.bayer.com/downloads/9202/9206/12248/Meet_Management_TOKYO_2012-11-21_Audio_Dekkers2.mp3</link>
      <description><![CDATA[Meet Management 2012 in Tokyo &#8211; Summary; Presentation by Dr. Marijn Dekkers, CEO of Bayer AG]]></description>
      <pubDate>Wed, 21 Nov 2012 11:00:00 GMT</pubDate>
      <author>bayermaildesk@bayermail.com (Bayer AG, Leverkusen, Germany)</author>
      <guid>http://www.webvideo.bayer.com/downloads/9202/9206/12248/Meet_Management_TOKYO_2012-11-21_Audio_Dekkers2.mp3</guid>
      <category>Business</category>
      <enclosure url="http://www.webvideo.bayer.com/downloads/9202/9206/12248/Meet_Management_TOKYO_2012-11-21_Audio_Dekkers2.mp3" length="8393711" type="audio/mpeg" />
      <itunes:author>Bayer AG, Leverkusen, Germany</itunes:author>
      <itunes:subtitle><![CDATA[]]></itunes:subtitle>
      <itunes:summary><![CDATA[Meet Management 2012 in Tokyo &#8211; Summary; Presentation by Dr. Marijn Dekkers, CEO of Bayer AG]]></itunes:summary>
      <itunes:duration>6:59</itunes:duration>
      <itunes:image href="http://www.webvideo.bayer.com" />
      <itunes:keywords>Chemistry, Pharmacy, Research, Innovation, HealthCare, MaterialScience, CropScience</itunes:keywords>
    </item>
    <item>
      <title>Meet Management 2012 in Tokyo - Bayer MaterialScience; Presentation by Patrick Thomas</title>
      <link>http://www.webvideo.bayer.com/downloads/9202/9206/12249/Meet_Management_TOKYO_2012-11-21_Audio_Thomas.mp3</link>
      <description><![CDATA[Meet Management 2012 in Tokyo &#8211; Bayer MaterialScience; Presentation by Patrick Thomas, CEO of Bayer MaterialScience AG]]></description>
      <pubDate>Wed, 21 Nov 2012 11:00:00 GMT</pubDate>
      <author>bayermaildesk@bayermail.com (Bayer AG, Leverkusen, Germany)</author>
      <guid>http://www.webvideo.bayer.com/downloads/9202/9206/12249/Meet_Management_TOKYO_2012-11-21_Audio_Thomas.mp3</guid>
      <category>Business</category>
      <enclosure url="http://www.webvideo.bayer.com/downloads/9202/9206/12249/Meet_Management_TOKYO_2012-11-21_Audio_Thomas.mp3" length="39738038" type="audio/mpeg" />
      <itunes:author>Bayer AG, Leverkusen, Germany</itunes:author>
      <itunes:subtitle><![CDATA[]]></itunes:subtitle>
      <itunes:summary><![CDATA[Meet Management 2012 in Tokyo &#8211; Bayer MaterialScience; Presentation by Patrick Thomas, CEO of Bayer MaterialScience AG]]></itunes:summary>
      <itunes:duration>33:06</itunes:duration>
      <itunes:image href="http://www.webvideo.bayer.com" />
      <itunes:keywords>Chemistry, Pharmacy, Research, Innovation, HealthCare, MaterialScience, CropScience</itunes:keywords>
    </item>
    <item>
      <title>Meet Management 2012 in Tokyo - Bayer CropScience; Presentation by Dr. Ruediger Scheitza</title>
      <link>http://www.webvideo.bayer.com/downloads/9202/9206/12250/Meet_Management_TOKYO_2012-11-21_Audio_Scheitza.mp3</link>
      <description><![CDATA[Meet Management 2012 in Tokyo &#8211; Bayer CropScience; Presentation by Dr. Ruediger Scheitza, Member of the Board of Management of Bayer CropScience AG]]></description>
      <pubDate>Wed, 21 Nov 2012 11:00:00 GMT</pubDate>
      <author>bayermaildesk@bayermail.com (Bayer AG, Leverkusen, Germany)</author>
      <guid>http://www.webvideo.bayer.com/downloads/9202/9206/12250/Meet_Management_TOKYO_2012-11-21_Audio_Scheitza.mp3</guid>
      <category>Business</category>
      <enclosure url="http://www.webvideo.bayer.com/downloads/9202/9206/12250/Meet_Management_TOKYO_2012-11-21_Audio_Scheitza.mp3" length="34347410" type="audio/mpeg" />
      <itunes:author>Bayer AG, Leverkusen, Germany</itunes:author>
      <itunes:subtitle><![CDATA[]]></itunes:subtitle>
      <itunes:summary><![CDATA[Meet Management 2012 in Tokyo &#8211; Bayer CropScience; Presentation by Dr. Ruediger Scheitza, Member of the Board of Management of Bayer CropScience AG]]></itunes:summary>
      <itunes:duration>28:37</itunes:duration>
      <itunes:image href="http://www.webvideo.bayer.com" />
      <itunes:keywords>Chemistry, Pharmacy, Research, Innovation, HealthCare, MaterialScience, CropScience</itunes:keywords>
    </item>
    <item>
      <title>Meet Management 2012 in Tokyo - Bayer HealthCare; Presentation by Dr. Joerg Reinhardt</title>
      <link>http://www.webvideo.bayer.com/downloads/9202/9206/12251/Meet_Management_TOKYO_2012-11-21_Audio_Reinhardt.mp3</link>
      <description><![CDATA[Meet Management 2012 in Tokyo &#8211; Bayer HealthCare; Presentation by Dr. Joerg Reinhardt, CEO of Bayer HealthCare AG]]></description>
      <pubDate>Wed, 21 Nov 2012 11:00:00 GMT</pubDate>
      <author>bayermaildesk@bayermail.com (Bayer AG, Leverkusen, Germany)</author>
      <guid>http://www.webvideo.bayer.com/downloads/9202/9206/12251/Meet_Management_TOKYO_2012-11-21_Audio_Reinhardt.mp3</guid>
      <category>Business</category>
      <enclosure url="http://www.webvideo.bayer.com/downloads/9202/9206/12251/Meet_Management_TOKYO_2012-11-21_Audio_Reinhardt.mp3" length="35836389" type="audio/mpeg" />
      <itunes:author>Bayer AG, Leverkusen, Germany</itunes:author>
      <itunes:subtitle><![CDATA[]]></itunes:subtitle>
      <itunes:summary><![CDATA[Meet Management 2012 in Tokyo &#8211; Bayer HealthCare; Presentation by Dr. Joerg Reinhardt, CEO of Bayer HealthCare AG]]></itunes:summary>
      <itunes:duration>29:51</itunes:duration>
      <itunes:image href="http://www.webvideo.bayer.com" />
      <itunes:keywords>Chemistry, Pharmacy, Research, Innovation, HealthCare, MaterialScience, CropScience</itunes:keywords>
    </item>
    <item>
      <title>Meet Management 2012 in Tokyo - Bayer in Asia/Pacific; Presentation by Prof. Dr. Wolfgang Plischke</title>
      <link>http://www.webvideo.bayer.com/downloads/9202/9206/12252/Meet_Management_TOKYO_2012-11-21_Audio_Plischke.mp3</link>
      <description><![CDATA[Meet Management 2012 in Tokyo &#8211; Bayer in Asia/Pacific; Presentation by Prof. Dr. Wolfgang Plischke, Member of the Board of Management of Bayer AG]]></description>
      <pubDate>Wed, 21 Nov 2012 11:00:00 GMT</pubDate>
      <author>bayermaildesk@bayermail.com (Bayer AG, Leverkusen, Germany)</author>
      <guid>http://www.webvideo.bayer.com/downloads/9202/9206/12252/Meet_Management_TOKYO_2012-11-21_Audio_Plischke.mp3</guid>
      <category>Business</category>
      <enclosure url="http://www.webvideo.bayer.com/downloads/9202/9206/12252/Meet_Management_TOKYO_2012-11-21_Audio_Plischke.mp3" length="24060912" type="audio/mpeg" />
      <itunes:author>Bayer AG, Leverkusen, Germany</itunes:author>
      <itunes:subtitle><![CDATA[]]></itunes:subtitle>
      <itunes:summary><![CDATA[Meet Management 2012 in Tokyo &#8211; Bayer in Asia/Pacific; Presentation by Prof. Dr. Wolfgang Plischke, Member of the Board of Management of Bayer AG]]></itunes:summary>
      <itunes:duration>20:03</itunes:duration>
      <itunes:image href="http://www.webvideo.bayer.com" />
      <itunes:keywords>Chemistry, Pharmacy, Research, Innovation, HealthCare, MaterialScience, CropScience</itunes:keywords>
    </item>
    <item>
      <title>Meet Management 2012 in Tokyo - Bayer Group; Presentation by Dr. Marijn Dekkers</title>
      <link>http://www.webvideo.bayer.com/downloads/9202/9206/12253/Meet_Management_TOKYO_2012-11-21_Audio_Dekkers1.mp3</link>
      <description><![CDATA[Meet Management 2012 in Tokyo &#8211; Bayer Group; Presentation by Dr. Marijn Dekkers, CEO of Bayer AG]]></description>
      <pubDate>Wed, 21 Nov 2012 11:00:00 GMT</pubDate>
      <author>bayermaildesk@bayermail.com (Bayer AG, Leverkusen, Germany)</author>
      <guid>http://www.webvideo.bayer.com/downloads/9202/9206/12253/Meet_Management_TOKYO_2012-11-21_Audio_Dekkers1.mp3</guid>
      <category>Business</category>
      <enclosure url="http://www.webvideo.bayer.com/downloads/9202/9206/12253/Meet_Management_TOKYO_2012-11-21_Audio_Dekkers1.mp3" length="47211670" type="audio/mpeg" />
      <itunes:author>Bayer AG, Leverkusen, Germany</itunes:author>
      <itunes:subtitle><![CDATA[]]></itunes:subtitle>
      <itunes:summary><![CDATA[Meet Management 2012 in Tokyo &#8211; Bayer Group; Presentation by Dr. Marijn Dekkers, CEO of Bayer AG]]></itunes:summary>
      <itunes:duration>39:20</itunes:duration>
      <itunes:image href="http://www.webvideo.bayer.com" />
      <itunes:keywords>Chemistry, Pharmacy, Research, Innovation, HealthCare, MaterialScience, CropScience</itunes:keywords>
    </item>
    <item>
      <title>October 30, 2012, Q3 2012 Investor Conference Call</title>
      <link>http://www.webvideo.bayer.com/downloads/9202/9206/12196/Bayer_CC_IR_121030_1.mp3</link>
      <description><![CDATA[Dr. Marijn Dekkers, CEO of Bayer AG, on the Q3 2012 Investor Conference Call. Followed by a discussion.]]></description>
      <pubDate>Tue, 30 Oct 2012 11:00:00 GMT</pubDate>
      <author>bayermaildesk@bayermail.com (Bayer AG, Leverkusen, Germany)</author>
      <guid>http://www.webvideo.bayer.com/downloads/9202/9206/12196/Bayer_CC_IR_121030_1.mp3</guid>
      <category>Business</category>
      <enclosure url="http://www.webvideo.bayer.com/downloads/9202/9206/12196/Bayer_CC_IR_121030_1.mp3" length="37368640" type="audio/mpeg" />
      <itunes:author>Bayer AG, Leverkusen, Germany</itunes:author>
      <itunes:subtitle><![CDATA[]]></itunes:subtitle>
      <itunes:summary><![CDATA[Dr. Marijn Dekkers, CEO of Bayer AG, on the Q3 2012 Investor Conference Call. Followed by a discussion.]]></itunes:summary>
      <itunes:duration>77:51</itunes:duration>
      <itunes:image href="http://www.webvideo.bayer.com" />
      <itunes:keywords>Pharmacy, Research, Innovation, HealthCare, MaterialScience, CropScience, Quarterly results</itunes:keywords>
    </item>
    <item>
      <title>October 24, 2012, Investor Conference Call - Riociguat Data at the CHEST 2012 Annual Meeting</title>
      <link>http://www.webvideo.bayer.com/downloads/9202/9206/12172/Bayer_CC_IR_121024.mp3</link>
      <description><![CDATA[Investor Conference Call: Data for Riociguat have been presented at the Riociguat Data at the CHEST 2012 Annual Meeting. Presentation followed by a discussion.]]></description>
      <pubDate>Wed, 24 Oct 2012 11:00:00 GMT</pubDate>
      <author>bayermaildesk@bayermail.com (Bayer AG, Leverkusen, Germany)</author>
      <guid>http://www.webvideo.bayer.com/downloads/9202/9206/12172/Bayer_CC_IR_121024.mp3</guid>
      <category>Business</category>
      <enclosure url="http://www.webvideo.bayer.com/downloads/9202/9206/12172/Bayer_CC_IR_121024.mp3" length="23343976" type="audio/mpeg" />
      <itunes:author>Bayer AG, Leverkusen, Germany</itunes:author>
      <itunes:subtitle><![CDATA[]]></itunes:subtitle>
      <itunes:summary><![CDATA[Investor Conference Call: Data for Riociguat have been presented at the Riociguat Data at the CHEST 2012 Annual Meeting. Presentation followed by a discussion.]]></itunes:summary>
      <itunes:duration>64:49</itunes:duration>
      <itunes:image href="http://www.webvideo.bayer.com" />
      <itunes:keywords>Pharma, Research, Innovation, HealthCare, Riociguat, CHEST, PAH, CTEPH</itunes:keywords>
    </item>
    <item>
      <title>July 31, 2012, Q2 2012 Investor Conference Call</title>
      <link>http://www.webvideo.bayer.com/downloads/9202/9206/12138/Bayer_CC_IR_120731.mp3</link>
      <description><![CDATA[Dr. Marijn Dekkers, CEO of Bayer AG, on the Q2 2012 Investor Conference Call. Followed by a discussion.]]></description>
      <pubDate>Tue, 31 Jul 2012 11:00:00 GMT</pubDate>
      <author>bayermaildesk@bayermail.com (Bayer AG, Leverkusen, Germany)</author>
      <guid>http://www.webvideo.bayer.com/downloads/9202/9206/12138/Bayer_CC_IR_120731.mp3</guid>
      <category>Business</category>
      <enclosure url="http://www.webvideo.bayer.com/downloads/9202/9206/12138/Bayer_CC_IR_120731.mp3" length="34000768" type="audio/mpeg" />
      <itunes:author>Bayer AG, Leverkusen, Germany</itunes:author>
      <itunes:subtitle><![CDATA[]]></itunes:subtitle>
      <itunes:summary><![CDATA[Dr. Marijn Dekkers, CEO of Bayer AG, on the Q2 2012 Investor Conference Call. Followed by a discussion.]]></itunes:summary>
      <itunes:duration>70:50</itunes:duration>
      <itunes:image href="http://www.webvideo.bayer.com" />
      <itunes:keywords>Pharmacy, Research, Innovation, HealthCare, MaterialScience, CropScience, Quarterly results</itunes:keywords>
    </item>
    <item>
      <title>June 12, 2012, Meet Management 2012 in New York</title>
      <link>http://www.webvideo.bayer.com/downloads/9202/9206/12122/Meet_Management_2012-06-12_NY_Audio-Aufzeichnung.mp3</link>
      <description><![CDATA[Presentation by Dr. Marijn Dekkers, CEO of Bayer AG, at the Meet Management 2012 Bayer Investor Day in New York]]></description>
      <pubDate>Tue, 12 Jun 2012 11:00:00 GMT</pubDate>
      <author>bayermaildesk@bayermail.com (Bayer AG, Leverkusen, Germany)</author>
      <guid>http://www.webvideo.bayer.com/downloads/9202/9206/12122/Meet_Management_2012-06-12_NY_Audio-Aufzeichnung.mp3</guid>
      <category>Business</category>
      <enclosure url="http://www.webvideo.bayer.com/downloads/9202/9206/12122/Meet_Management_2012-06-12_NY_Audio-Aufzeichnung.mp3" length="73011208" type="audio/mpeg" />
      <itunes:author>Bayer AG, Leverkusen, Germany</itunes:author>
      <itunes:subtitle><![CDATA[]]></itunes:subtitle>
      <itunes:summary><![CDATA[Presentation by Dr. Marijn Dekkers, CEO of Bayer AG, at the Meet Management 2012 Bayer Investor Day in New York]]></itunes:summary>
      <itunes:duration>30:25</itunes:duration>
      <itunes:image href="http://www.webvideo.bayer.com" />
      <itunes:keywords>Chemistry, Pharmacy, Research, Innovation, HealthCare, MaterialScience, CropScience</itunes:keywords>
    </item>
    <item>
      <title>April 26, 2012, Q1 2012 Investor Conference Call</title>
      <link>http://www.webvideo.bayer.com/downloads/9202/9206/12089/Bayer_CC_IR_120426.mp3</link>
      <description><![CDATA[Dr. Marijn Dekkers, CEO of Bayer AG, on the Q1 2012 Investor Conference Call. Followed by a discussion.]]></description>
      <pubDate>Thu, 26 Apr 2012 11:00:00 GMT</pubDate>
      <author>bayermaildesk@bayermail.com (Bayer AG, Leverkusen, Germany)</author>
      <guid>http://www.webvideo.bayer.com/downloads/9202/9206/12089/Bayer_CC_IR_120426.mp3</guid>
      <category>Business</category>
      <enclosure url="http://www.webvideo.bayer.com/downloads/9202/9206/12089/Bayer_CC_IR_120426.mp3" length="38255269" type="audio/mpeg" />
      <itunes:author>Bayer AG, Leverkusen, Germany</itunes:author>
      <itunes:subtitle><![CDATA[]]></itunes:subtitle>
      <itunes:summary><![CDATA[Dr. Marijn Dekkers, CEO of Bayer AG, on the Q1 2012 Investor Conference Call. Followed by a discussion.]]></itunes:summary>
      <itunes:duration>79:36</itunes:duration>
      <itunes:image href="http://www.webvideo.bayer.com" />
      <itunes:keywords>Pharmacy, Research, Innovation, HealthCare, MaterialScience, CropScience, Quarterly results</itunes:keywords>
    </item>
    <item>
      <title>March 26, 2012, Investor Conference Call - Rivaroxaban Data at the ACC.12 Annual Scientific Session</title>
      <link>http://www.webvideo.bayer.com/downloads/9202/9206/12069/Bayer_CC_IR_120326.mp3</link>
      <description><![CDATA[Investor Conference Call: Data for Rivaroxaban have been presented at the ACC.12 Annual Scientific Session. Presentation followed by a discussion.]]></description>
      <pubDate>Mon, 26 Mar 2012 11:00:00 GMT</pubDate>
      <author>bayermaildesk@bayermail.com (Bayer AG, Leverkusen, Germany)</author>
      <guid>http://www.webvideo.bayer.com/downloads/9202/9206/12069/Bayer_CC_IR_120326.mp3</guid>
      <category>Business</category>
      <enclosure url="http://www.webvideo.bayer.com/downloads/9202/9206/12069/Bayer_CC_IR_120326.mp3" length="12563200" type="audio/mpeg" />
      <itunes:author>Bayer AG, Leverkusen, Germany</itunes:author>
      <itunes:subtitle><![CDATA[]]></itunes:subtitle>
      <itunes:summary><![CDATA[Investor Conference Call: Data for Rivaroxaban have been presented at the ACC.12 Annual Scientific Session. Presentation followed by a discussion.]]></itunes:summary>
      <itunes:duration>26:10</itunes:duration>
      <itunes:image href="http://www.webvideo.bayer.com" />
      <itunes:keywords>Pharma, Research, Innovation, HealthCare, Rivaroxaban,ACC</itunes:keywords>
    </item>
    <item>
      <title>March 14, 2012, Meet Management 2012</title>
      <link>http://www.webvideo.bayer.com/downloads/9202/9206/12065/Bayer_CC_IR_120314.mp3</link>
      <description><![CDATA[Presentation by Dr. Marijn Dekkers, CEO of Bayer AG, at the Meet Management 2012 Bayer Investor Day in Leverkusen]]></description>
      <pubDate>Wed, 14 Mar 2012 11:00:00 GMT</pubDate>
      <author>bayermaildesk@bayermail.com (Bayer AG, Leverkusen, Germany)</author>
      <guid>http://www.webvideo.bayer.com/downloads/9202/9206/12065/Bayer_CC_IR_120314.mp3</guid>
      <category>Business</category>
      <enclosure url="http://www.webvideo.bayer.com/downloads/9202/9206/12065/Bayer_CC_IR_120314.mp3" length="10959751" type="audio/mpeg" />
      <itunes:author>Bayer AG, Leverkusen, Germany</itunes:author>
      <itunes:subtitle><![CDATA[]]></itunes:subtitle>
      <itunes:summary><![CDATA[Presentation by Dr. Marijn Dekkers, CEO of Bayer AG, at the Meet Management 2012 Bayer Investor Day in Leverkusen]]></itunes:summary>
      <itunes:duration>22:43</itunes:duration>
      <itunes:image href="http://www.webvideo.bayer.com" />
      <itunes:keywords>Chemistry, Pharmacy, Research, Innovation, HealthCare, MaterialScience, CropScience</itunes:keywords>
    </item>
    <item>
      <title>February 28, 2012, FY/Q4 2011 Investor Conference Call</title>
      <link>http://www.webvideo.bayer.com/downloads/9202/9206/12053/2012-02-28_Bayer_CC_IR_120228_1.mp3</link>
      <description><![CDATA[Dr. Marijn Dekkers, CEO of Bayer AG, at the FY/Q4 2011 Investor Conference Call. Followed by a discussion.]]></description>
      <pubDate>Tue, 28 Feb 2012 11:00:00 GMT</pubDate>
      <author>bayermaildesk@bayermail.com (Bayer AG, Leverkusen, Germany)</author>
      <guid>http://www.webvideo.bayer.com/downloads/9202/9206/12053/2012-02-28_Bayer_CC_IR_120228_1.mp3</guid>
      <category>Business</category>
      <enclosure url="http://www.webvideo.bayer.com/downloads/9202/9206/12053/2012-02-28_Bayer_CC_IR_120228_1.mp3" length="42007737" type="audio/mpeg" />
      <itunes:author>Bayer AG, Leverkusen, Germany</itunes:author>
      <itunes:subtitle><![CDATA[]]></itunes:subtitle>
      <itunes:summary><![CDATA[Dr. Marijn Dekkers, CEO of Bayer AG, at the FY/Q4 2011 Investor Conference Call. Followed by a discussion.]]></itunes:summary>
      <itunes:duration>87:24</itunes:duration>
      <itunes:image href="http://www.webvideo.bayer.com" />
      <itunes:keywords>Annual Report, Chemistry, Pharmacy, Research, Innovation, HealthCare, MaterialScience, CropScience</itunes:keywords>
    </item>
    <item>
      <title>January 23, 2012, Investor Conference Call - Regorafenib Data at the 2012 ASCO-GI Congress</title>
      <link>http://www.webvideo.bayer.com/downloads/9202/9206/12009/Bayer_CC_IR_120123.mp3</link>
      <description><![CDATA[Investor Conference Call: Data for Regorafenib have been presented at the 2012 ASCO-GI Congress. Presentation followed by a discussion.]]></description>
      <pubDate>Mon, 23 Jan 2012 11:00:00 GMT</pubDate>
      <author>bayermaildesk@bayermail.com (Bayer AG, Leverkusen, Germany)</author>
      <guid>http://www.webvideo.bayer.com/downloads/9202/9206/12009/Bayer_CC_IR_120123.mp3</guid>
      <category>Business</category>
      <enclosure url="http://www.webvideo.bayer.com/downloads/9202/9206/12009/Bayer_CC_IR_120123.mp3" length="16039168" type="audio/mpeg" />
      <itunes:author>Bayer AG, Leverkusen, Germany</itunes:author>
      <itunes:subtitle><![CDATA[]]></itunes:subtitle>
      <itunes:summary><![CDATA[Investor Conference Call: Data for Regorafenib have been presented at the 2012 ASCO-GI Congress. Presentation followed by a discussion.]]></itunes:summary>
      <itunes:duration>33:24</itunes:duration>
      <itunes:image href="http://www.webvideo.bayer.com" />
      <itunes:keywords>Pharma, Research, Innovation, HealthCare, Regorafenib, ASCO</itunes:keywords>
    </item>
    <item>
      <title>China Investor Conference 2011 - Bayer in China; Presentation by Dr. Marijn Dekkers</title>
      <link>http://www.webvideo.bayer.com/downloads/9202/9206/11987/001-Presentation_Mr-Dekkers.mp3</link>
      <description><![CDATA[China Investor Conference 2011 &#8211; Bayer in China; Presentation by Dr. Marijn Dekkers]]></description>
      <pubDate>Thu, 17 Nov 2011 11:00:00 GMT</pubDate>
      <author>bayermaildesk@bayermail.com (Bayer AG, Leverkusen, Germany)</author>
      <guid>http://www.webvideo.bayer.com/downloads/9202/9206/11987/001-Presentation_Mr-Dekkers.mp3</guid>
      <category>Business</category>
      <enclosure url="http://www.webvideo.bayer.com/downloads/9202/9206/11987/001-Presentation_Mr-Dekkers.mp3" length="43320735" type="audio/mpeg" />
      <itunes:author>Bayer AG, Leverkusen, Germany</itunes:author>
      <itunes:subtitle><![CDATA[]]></itunes:subtitle>
      <itunes:summary><![CDATA[China Investor Conference 2011 &#8211; Bayer in China; Presentation by Dr. Marijn Dekkers]]></itunes:summary>
      <itunes:duration>45:05</itunes:duration>
      <itunes:image href="http://www.webvideo.bayer.com" />
      <itunes:keywords>Chemistry, Pharmacy, Research, Innovation, HealthCare, MaterialScience, CropScienc</itunes:keywords>
    </item>
    <item>
      <title>China Investor Conference 2011 - Bayer HealthCare in China; Presentation by Andreas Fibig</title>
      <link>http://www.webvideo.bayer.com/downloads/9202/9206/11986/002-Presentation_Part_1_BHC_Mr-Fibig.mp3</link>
      <description><![CDATA[China Investor Conference 2011 &#8211; Bayer HealthCare in China; Presentation by Andreas Fibig]]></description>
      <pubDate>Thu, 17 Nov 2011 11:00:00 GMT</pubDate>
      <author>bayermaildesk@bayermail.com (Bayer AG, Leverkusen, Germany)</author>
      <guid>http://www.webvideo.bayer.com/downloads/9202/9206/11986/002-Presentation_Part_1_BHC_Mr-Fibig.mp3</guid>
      <category>Business</category>
      <enclosure url="http://www.webvideo.bayer.com/downloads/9202/9206/11986/002-Presentation_Part_1_BHC_Mr-Fibig.mp3" length="25070756" type="audio/mpeg" />
      <itunes:author>Bayer AG, Leverkusen, Germany</itunes:author>
      <itunes:subtitle><![CDATA[]]></itunes:subtitle>
      <itunes:summary><![CDATA[China Investor Conference 2011 &#8211; Bayer HealthCare in China; Presentation by Andreas Fibig]]></itunes:summary>
      <itunes:duration>34:45</itunes:duration>
      <itunes:image href="http://www.webvideo.bayer.com" />
      <itunes:keywords>Chemistry, Pharmacy, Research, Innovation, HealthCare, MaterialScience, CropScienc</itunes:keywords>
    </item>
    <item>
      <title>China Investor Conference 2011 - Bayer HealthCare in China; Presentation by Chris Lee</title>
      <link>http://www.webvideo.bayer.com/downloads/9202/9206/11985/003-Presentation_Part_2_BHC_Mr-Lee.mp3</link>
      <description><![CDATA[China Investor Conference 2011 &#8211; Bayer HealthCare in China; Presentation by Chris Lee]]></description>
      <pubDate>Thu, 17 Nov 2011 11:00:00 GMT</pubDate>
      <author>bayermaildesk@bayermail.com (Bayer AG, Leverkusen, Germany)</author>
      <guid>http://www.webvideo.bayer.com/downloads/9202/9206/11985/003-Presentation_Part_2_BHC_Mr-Lee.mp3</guid>
      <category>Business</category>
      <enclosure url="http://www.webvideo.bayer.com/downloads/9202/9206/11985/003-Presentation_Part_2_BHC_Mr-Lee.mp3" length="40721447" type="audio/mpeg" />
      <itunes:author>Bayer AG, Leverkusen, Germany</itunes:author>
      <itunes:subtitle><![CDATA[]]></itunes:subtitle>
      <itunes:summary><![CDATA[China Investor Conference 2011 &#8211; Bayer HealthCare in China; Presentation by Chris Lee]]></itunes:summary>
      <itunes:duration>42:22</itunes:duration>
      <itunes:image href="http://www.webvideo.bayer.com" />
      <itunes:keywords>Chemistry, Pharmacy, Research, Innovation, HealthCare, MaterialScience, CropScienc</itunes:keywords>
    </item>
    <item>
      <title>China Investor Conference 2011 - Discussion session 1: Bayer Group and Bayer HealthCare</title>
      <link>http://www.webvideo.bayer.com/downloads/9202/9206/11984/004-Q_A-sessin_group___BHC.mp3</link>
      <description><![CDATA[China Investor Conference 2011 &#8211; Discussion session 1: Bayer Group and Bayer HealthCare]]></description>
      <pubDate>Thu, 17 Nov 2011 11:00:00 GMT</pubDate>
      <author>bayermaildesk@bayermail.com (Bayer AG, Leverkusen, Germany)</author>
      <guid>http://www.webvideo.bayer.com/downloads/9202/9206/11984/004-Q_A-sessin_group___BHC.mp3</guid>
      <category>Business</category>
      <enclosure url="http://www.webvideo.bayer.com/downloads/9202/9206/11984/004-Q_A-sessin_group___BHC.mp3" length="52653764" type="audio/mpeg" />
      <itunes:author>Bayer AG, Leverkusen, Germany</itunes:author>
      <itunes:subtitle><![CDATA[]]></itunes:subtitle>
      <itunes:summary><![CDATA[China Investor Conference 2011 &#8211; Discussion session 1: Bayer Group and Bayer HealthCare]]></itunes:summary>
      <itunes:duration>54:47</itunes:duration>
      <itunes:image href="http://www.webvideo.bayer.com" />
      <itunes:keywords>Chemistry, Pharmacy, Research, Innovation, HealthCare, MaterialScience, CropScienc</itunes:keywords>
    </item>
    <item>
      <title>China Investor Conference 2011 - Bayer CropScience in China; Presentation by Frank Dietrich</title>
      <link>http://www.webvideo.bayer.com/downloads/9202/9206/11983/005-Presentation_BCS_Mr-Dietrich.mp3</link>
      <description><![CDATA[China Investor Conference 2011 &#8211; Bayer CropScience in China; Presentation by Frank Dietrich]]></description>
      <pubDate>Thu, 17 Nov 2011 11:00:00 GMT</pubDate>
      <author>bayermaildesk@bayermail.com (Bayer AG, Leverkusen, Germany)</author>
      <guid>http://www.webvideo.bayer.com/downloads/9202/9206/11983/005-Presentation_BCS_Mr-Dietrich.mp3</guid>
      <category>Business</category>
      <enclosure url="http://www.webvideo.bayer.com/downloads/9202/9206/11983/005-Presentation_BCS_Mr-Dietrich.mp3" length="45559742" type="audio/mpeg" />
      <itunes:author>Bayer AG, Leverkusen, Germany</itunes:author>
      <itunes:subtitle><![CDATA[]]></itunes:subtitle>
      <itunes:summary><![CDATA[China Investor Conference 2011 &#8211; Bayer CropScience in China; Presentation by Frank Dietrich]]></itunes:summary>
      <itunes:duration>47:24</itunes:duration>
      <itunes:image href="http://www.webvideo.bayer.com" />
      <itunes:keywords>Chemistry, Pharmacy, Research, Innovation, HealthCare, MaterialScience, CropScienc</itunes:keywords>
    </item>
    <item>
      <title>China Investor Conference 2011 - Bayer MaterialScience in China; Presentation by Patrick Thomas</title>
      <link>http://www.webvideo.bayer.com/downloads/9202/9206/11982/006-Presentation_BMS_Mr-Thomas.mp3</link>
      <description><![CDATA[China Investor Conference 2011 &#8211; Bayer MaterialScience in China; Presentation by Patrick Thomas]]></description>
      <pubDate>Thu, 17 Nov 2011 11:00:00 GMT</pubDate>
      <author>bayermaildesk@bayermail.com (Bayer AG, Leverkusen, Germany)</author>
      <guid>http://www.webvideo.bayer.com/downloads/9202/9206/11982/006-Presentation_BMS_Mr-Thomas.mp3</guid>
      <category>Business</category>
      <enclosure url="http://www.webvideo.bayer.com/downloads/9202/9206/11982/006-Presentation_BMS_Mr-Thomas.mp3" length="42277091" type="audio/mpeg" />
      <itunes:author>Bayer AG, Leverkusen, Germany</itunes:author>
      <itunes:subtitle><![CDATA[]]></itunes:subtitle>
      <itunes:summary><![CDATA[China Investor Conference 2011 &#8211; Bayer MaterialScience in China; Presentation by Patrick Thomas]]></itunes:summary>
      <itunes:duration>43:59</itunes:duration>
      <itunes:image href="http://www.webvideo.bayer.com" />
      <itunes:keywords>Chemistry, Pharmacy, Research, Innovation, HealthCare, MaterialScience, CropScienc</itunes:keywords>
    </item>
    <item>
      <title>China Investor Conference 2011 - Discussion session 2: Bayer CropScience and Bayer MaterialScience</title>
      <link>http://www.webvideo.bayer.com/downloads/9202/9206/11981/007-Q_A_session_BCS_BMS.mp3</link>
      <description><![CDATA[China Investor Conference 2011 &#8211; Discussion session 2: Bayer CropScience and Bayer MaterialScience]]></description>
      <pubDate>Thu, 17 Nov 2011 11:00:00 GMT</pubDate>
      <author>bayermaildesk@bayermail.com (Bayer AG, Leverkusen, Germany)</author>
      <guid>http://www.webvideo.bayer.com/downloads/9202/9206/11981/007-Q_A_session_BCS_BMS.mp3</guid>
      <category>Business</category>
      <enclosure url="http://www.webvideo.bayer.com/downloads/9202/9206/11981/007-Q_A_session_BCS_BMS.mp3" length="25548693" type="audio/mpeg" />
      <itunes:author>Bayer AG, Leverkusen, Germany</itunes:author>
      <itunes:subtitle><![CDATA[]]></itunes:subtitle>
      <itunes:summary><![CDATA[China Investor Conference 2011 &#8211; Discussion session 2: Bayer CropScience and Bayer MaterialScience]]></itunes:summary>
      <itunes:duration>26:33</itunes:duration>
      <itunes:image href="http://www.webvideo.bayer.com" />
      <itunes:keywords>Chemistry, Pharmacy, Research, Innovation, HealthCare, MaterialScience, CropScienc</itunes:keywords>
    </item>
    <item>
      <title>November 14, 2011, Investor Conference Call - Rivaroxaban Data at the 2011 AHA Scientific Session 2011</title>
      <link>http://www.webvideo.bayer.com/downloads/9202/9206/11926/Bayer_CC_IR_111114.mp3</link>
      <description><![CDATA[Investor Conference Call: Data for Rivaroxaban have been presented at the 2011 AHA Scientific Sessions. Presentation followed by a discussion.]]></description>
      <pubDate>Mon, 14 Nov 2011 11:00:00 GMT</pubDate>
      <author>bayermaildesk@bayermail.com (Bayer AG, Leverkusen, Germany)</author>
      <guid>http://www.webvideo.bayer.com/downloads/9202/9206/11926/Bayer_CC_IR_111114.mp3</guid>
      <category>Business</category>
      <enclosure url="http://www.webvideo.bayer.com/downloads/9202/9206/11926/Bayer_CC_IR_111114.mp3" length="25286310" type="audio/mpeg" />
      <itunes:author>Bayer AG, Leverkusen, Germany</itunes:author>
      <itunes:subtitle><![CDATA[]]></itunes:subtitle>
      <itunes:summary><![CDATA[Investor Conference Call: Data for Rivaroxaban have been presented at the 2011 AHA Scientific Sessions. Presentation followed by a discussion.]]></itunes:summary>
      <itunes:duration>52:34</itunes:duration>
      <itunes:image href="http://www.webvideo.bayer.com" />
      <itunes:keywords>Pharma, Forschung, Innovation, HealthCare, Xarelto, Rivaroxaban</itunes:keywords>
    </item>
    <item>
      <title>October 27, 2011, Q3 2011 Investor Conference Call</title>
      <link>http://www.webvideo.bayer.com/downloads/9202/9206/11922/Bayer_CC_IR_111027_1.mp3</link>
      <description><![CDATA[Dr. Marijn Dekkers, CEO of Bayer AG, on the Q3 2011 Investor Conference Call. Followed by a discussion.]]></description>
      <pubDate>Thu, 27 Oct 2011 11:00:00 GMT</pubDate>
      <author>bayermaildesk@bayermail.com (Bayer AG, Leverkusen, Germany)</author>
      <guid>http://www.webvideo.bayer.com/downloads/9202/9206/11922/Bayer_CC_IR_111027_1.mp3</guid>
      <category>Business</category>
      <enclosure url="http://www.webvideo.bayer.com/downloads/9202/9206/11922/Bayer_CC_IR_111027_1.mp3" length="29606806" type="audio/mpeg" />
      <itunes:author>Bayer AG, Leverkusen, Germany</itunes:author>
      <itunes:subtitle><![CDATA[]]></itunes:subtitle>
      <itunes:summary><![CDATA[Dr. Marijn Dekkers, CEO of Bayer AG, on the Q3 2011 Investor Conference Call. Followed by a discussion.]]></itunes:summary>
      <itunes:duration>61:35</itunes:duration>
      <itunes:image href="http://www.webvideo.bayer.com" />
      <itunes:keywords>Pharmacy, Research, Innovation, HealthCare, MaterialScience, CropScience, Quarterly results</itunes:keywords>
    </item>
    <item>
      <title>July 28, 2011, Q2 2011 Investor Conference Call</title>
      <link>http://www.webvideo.bayer.com/downloads/9202/9206/11856/Bayer_CC_IR_110728.mp3</link>
      <description><![CDATA[Dr. Marijn Dekkers, CEO of Bayer AG, on the Q2 2011 Investor Conference Call. Followed by a discussion.]]></description>
      <pubDate>Thu, 28 Jul 2011 11:00:00 GMT</pubDate>
      <author>bayermaildesk@bayermail.com (Bayer AG, Leverkusen, Germany)</author>
      <guid>http://www.webvideo.bayer.com/downloads/9202/9206/11856/Bayer_CC_IR_110728.mp3</guid>
      <category>Business</category>
      <enclosure url="http://www.webvideo.bayer.com/downloads/9202/9206/11856/Bayer_CC_IR_110728.mp3" length="28743078" type="audio/mpeg" />
      <itunes:author>Bayer AG, Leverkusen, Germany</itunes:author>
      <itunes:subtitle><![CDATA[]]></itunes:subtitle>
      <itunes:summary><![CDATA[Dr. Marijn Dekkers, CEO of Bayer AG, on the Q2 2011 Investor Conference Call. Followed by a discussion.]]></itunes:summary>
      <itunes:duration>69:44</itunes:duration>
      <itunes:image href="http://www.webvideo.bayer.com" />
      <itunes:keywords>Pharmacy, Research, Innovation, HealthCare, MaterialScience, CropScience, Quarterly results</itunes:keywords>
    </item>
    <item>
      <title>April 28, 2011, Q1 2011 Investor Conference Call</title>
      <link>http://www.webvideo.bayer.com/downloads/9202/9206/11776/Bayer_CC_IR_110428.mp3</link>
      <description><![CDATA[Dr. Marijn Dekkers, CEO of Bayer AG, on the Q1 2011 Investor Conference Call. Followed by a discussion.]]></description>
      <pubDate>Thu, 28 Apr 2011 11:00:00 GMT</pubDate>
      <author>bayermaildesk@bayermail.com (Bayer AG, Leverkusen, Germany)</author>
      <guid>http://www.webvideo.bayer.com/downloads/9202/9206/11776/Bayer_CC_IR_110428.mp3</guid>
      <category>Business</category>
      <enclosure url="http://www.webvideo.bayer.com/downloads/9202/9206/11776/Bayer_CC_IR_110428.mp3" length="32972608" type="audio/mpeg" />
      <itunes:author>Bayer AG, Leverkusen, Germany</itunes:author>
      <itunes:subtitle><![CDATA[]]></itunes:subtitle>
      <itunes:summary><![CDATA[Dr. Marijn Dekkers, CEO of Bayer AG, on the Q1 2011 Investor Conference Call. Followed by a discussion.]]></itunes:summary>
      <itunes:duration>68:41</itunes:duration>
      <itunes:image href="http://www.webvideo.bayer.com" />
      <itunes:keywords>Pharmacy, Research, Innovation, HealthCare, MaterialScience, CropScience, Quarterly results</itunes:keywords>
    </item>
    <item>
      <title>April 5, 2011, Investor Conference Call - Rivaroxaban Data at the ACC Scientific Session 2011</title>
      <link>http://www.webvideo.bayer.com/downloads/9202/9206/11757/Bayer_CC_IR_110405.mp3</link>
      <description><![CDATA[Investor Conference Call: Data for Rivaroxaban have been presented at the ACC Scientific Session 2011. Presentation followed by a discussion.]]></description>
      <pubDate>Tue, 5 Apr 2011 11:00:00 GMT</pubDate>
      <author>bayermaildesk@bayermail.com (Bayer AG, Leverkusen, Germany)</author>
      <guid>http://www.webvideo.bayer.com/downloads/9202/9206/11757/Bayer_CC_IR_110405.mp3</guid>
      <category>Business</category>
      <enclosure url="http://www.webvideo.bayer.com/downloads/9202/9206/11757/Bayer_CC_IR_110405.mp3" length="27353728" type="audio/mpeg" />
      <itunes:author>Bayer AG, Leverkusen, Germany</itunes:author>
      <itunes:subtitle><![CDATA[]]></itunes:subtitle>
      <itunes:summary><![CDATA[Investor Conference Call: Data for Rivaroxaban have been presented at the ACC Scientific Session 2011. Presentation followed by a discussion.]]></itunes:summary>
      <itunes:duration>56:59</itunes:duration>
      <itunes:image href="http://www.webvideo.bayer.com" />
      <itunes:keywords>Pharma, Forschung, Innovation, HealthCare, Xarelto, Rivaroxaban</itunes:keywords>
    </item>
    <item>
      <title>February 28, 2011, FY/Q4 2010 Investor Conference Call</title>
      <link>http://www.webvideo.bayer.com/downloads/9202/9206/11727/Bayer_CC_IR_110228.mp3</link>
      <description><![CDATA[Dr. Marijn Dekkers, CEO of Bayer AG, at the FY/Q4 2010 Investor Conference Call. Followed by a discussion.]]></description>
      <pubDate>Mon, 28 Feb 2011 11:00:00 GMT</pubDate>
      <author>bayermaildesk@bayermail.com (Bayer AG, Leverkusen, Germany)</author>
      <guid>http://www.webvideo.bayer.com/downloads/9202/9206/11727/Bayer_CC_IR_110228.mp3</guid>
      <category>Business</category>
      <enclosure url="http://www.webvideo.bayer.com/downloads/9202/9206/11727/Bayer_CC_IR_110228.mp3" length="35045440" type="audio/mpeg" />
      <itunes:author>Bayer AG, Leverkusen, Germany</itunes:author>
      <itunes:subtitle><![CDATA[]]></itunes:subtitle>
      <itunes:summary><![CDATA[Dr. Marijn Dekkers, CEO of Bayer AG, at the FY/Q4 2010 Investor Conference Call. Followed by a discussion.]]></itunes:summary>
      <itunes:duration>73:00</itunes:duration>
      <itunes:image href="http://www.webvideo.bayer.com" />
      <itunes:keywords>Chemistry, Pharmacy, Research, Innovation, HealthCare, MaterialScience, CropScienc</itunes:keywords>
    </item>
    <item>
      <title>October 28, 2010, Q3 2010 Investor Conference Call</title>
      <link>http://www.webvideo.bayer.com/downloads/9202/9206/11531/Bayer_CC_IR_101028.mp3</link>
      <description><![CDATA[Dr. Marijn Dekkers, CEO of Bayer AG, at the Q3 2010 Investor Conference Call. Followed by a discussion.]]></description>
      <pubDate>Thu, 28 Oct 2010 11:00:00 GMT</pubDate>
      <author>bayermaildesk@bayermail.com (Bayer AG, Leverkusen, Germany)</author>
      <guid>http://www.webvideo.bayer.com/downloads/9202/9206/11531/Bayer_CC_IR_101028.mp3</guid>
      <category>Business</category>
      <enclosure url="http://www.webvideo.bayer.com/downloads/9202/9206/11531/Bayer_CC_IR_101028.mp3" length="39959104" type="audio/mpeg" />
      <itunes:author>Bayer AG, Leverkusen, Germany</itunes:author>
      <itunes:subtitle><![CDATA[]]></itunes:subtitle>
      <itunes:summary><![CDATA[Dr. Marijn Dekkers, CEO of Bayer AG, at the Q3 2010 Investor Conference Call. Followed by a discussion.]]></itunes:summary>
      <itunes:duration>83:14</itunes:duration>
      <itunes:image href="http://www.webvideo.bayer.com" />
      <itunes:keywords>Chemistry, Pharmacy, Research, Innovation, HealthCare, MaterialScience, CropScience</itunes:keywords>
    </item>
    <item>
      <title>August 31, 2010, Investor Conference Call - Rivaroxaban Data at the ESC Conference 2010</title>
      <link>http://www.webvideo.bayer.com/downloads/9202/9206/11457/Bayer_CC_IR_100831.mp3</link>
      <description><![CDATA[Investor Conference Call: Data for Rivaroxaban have been presented at the ESC Conference 2010. Presentation followed by a discussion.]]></description>
      <pubDate>Tue, 31 Aug 2010 11:00:00 GMT</pubDate>
      <author>bayermaildesk@bayermail.com (Bayer AG, Leverkusen, Germany)</author>
      <guid>http://www.webvideo.bayer.com/downloads/9202/9206/11457/Bayer_CC_IR_100831.mp3</guid>
      <category>Business</category>
      <enclosure url="http://www.webvideo.bayer.com/downloads/9202/9206/11457/Bayer_CC_IR_100831.mp3" length="28416640" type="audio/mpeg" />
      <itunes:author>Bayer AG, Leverkusen, Germany</itunes:author>
      <itunes:subtitle><![CDATA[]]></itunes:subtitle>
      <itunes:summary><![CDATA[Investor Conference Call: Data for Rivaroxaban have been presented at the ESC Conference 2010. Presentation followed by a discussion.]]></itunes:summary>
      <itunes:duration>59:11</itunes:duration>
      <itunes:image href="http://www.webvideo.bayer.com" />
      <itunes:keywords>Pharma,Research,Innovation,HealthCare,Xarelto,Rivaroxaban</itunes:keywords>
    </item>
    <item>
      <title>July 29, 2010, Q2 2010 Investor Conference Call</title>
      <link>http://www.webvideo.bayer.com/downloads/9202/9206/11428/Bayer_CC_IR_100729.mp3</link>
      <description><![CDATA[Werner Wenning, CEO of Bayer AG, at the Q2 2010 Investor Conference Call. Followed by a discussion.]]></description>
      <pubDate>Thu, 29 Jul 2010 11:00:00 GMT</pubDate>
      <author>bayermaildesk@bayermail.com (Bayer AG, Leverkusen, Germany)</author>
      <guid>http://www.webvideo.bayer.com/downloads/9202/9206/11428/Bayer_CC_IR_100729.mp3</guid>
      <category>Business</category>
      <enclosure url="http://www.webvideo.bayer.com/downloads/9202/9206/11428/Bayer_CC_IR_100729.mp3" length="40410112" type="audio/mpeg" />
      <itunes:author>Bayer AG, Leverkusen, Germany</itunes:author>
      <itunes:subtitle><![CDATA[]]></itunes:subtitle>
      <itunes:summary><![CDATA[Werner Wenning, CEO of Bayer AG, at the Q2 2010 Investor Conference Call. Followed by a discussion.]]></itunes:summary>
      <itunes:duration>1:24:10</itunes:duration>
      <itunes:image href="http://www.webvideo.bayer.com" />
      <itunes:keywords>Chemistry, Pharmacy, Research, Innovation, HealthCare, MaterialScience, CropScience</itunes:keywords>
    </item>
    <item>
      <title>April 29, 2010, Q1 2010 Investor Conference Call</title>
      <link>http://www.webvideo.bayer.com/downloads/9202/9206/11330/Bayer_CC_IR_100429.mp3</link>
      <description><![CDATA[Werner Wenning, CEO of Bayer AG, at the Q1 2010 Investor Conference Call. Followed by a discussion.]]></description>
      <pubDate>Thu, 29 Apr 2010 11:00:00 GMT</pubDate>
      <author>bayermaildesk@bayermail.com (Bayer AG, Leverkusen, Germany)</author>
      <guid>http://www.webvideo.bayer.com/downloads/9202/9206/11330/Bayer_CC_IR_100429.mp3</guid>
      <category>Business</category>
      <enclosure url="http://www.webvideo.bayer.com/downloads/9202/9206/11330/Bayer_CC_IR_100429.mp3" length="33451840" type="audio/mpeg" />
      <itunes:author>Bayer AG, Leverkusen, Germany</itunes:author>
      <itunes:subtitle><![CDATA[]]></itunes:subtitle>
      <itunes:summary><![CDATA[Werner Wenning, CEO of Bayer AG, at the Q1 2010 Investor Conference Call. Followed by a discussion.]]></itunes:summary>
      <itunes:duration>1:09:40</itunes:duration>
      <itunes:image href="http://www.webvideo.bayer.com" />
      <itunes:keywords>Chemistry, Pharmacy, Research, Innovation, HealthCare, MaterialScience, CropScience</itunes:keywords>
    </item>
    <item>
      <title>February 26, 2010, FY/Q4 2009 Investor Conference Call</title>
      <link>http://www.webvideo.bayer.com/downloads/9202/9206/11248/Bayer_CC_IR_100226.mp3</link>
      <description><![CDATA[Werner Wenning, CEO of Bayer AG, at the FY/Q4 2009 Investor Conference Call. Followed by a discussion.]]></description>
      <pubDate>Fri, 26 Feb 2010 11:00:00 GMT</pubDate>
      <author>bayermaildesk@bayermail.com (Bayer AG, Leverkusen, Germany)</author>
      <guid>http://www.webvideo.bayer.com/downloads/9202/9206/11248/Bayer_CC_IR_100226.mp3</guid>
      <category>Business</category>
      <enclosure url="http://www.webvideo.bayer.com/downloads/9202/9206/11248/Bayer_CC_IR_100226.mp3" length="47911936" type="audio/mpeg" />
      <itunes:author>Bayer AG, Leverkusen, Germany</itunes:author>
      <itunes:subtitle><![CDATA[]]></itunes:subtitle>
      <itunes:summary><![CDATA[Werner Wenning, CEO of Bayer AG, at the FY/Q4 2009 Investor Conference Call. Followed by a discussion.]]></itunes:summary>
      <itunes:duration>1:39:48</itunes:duration>
      <itunes:image href="http://www.webvideo.bayer.com" />
      <itunes:keywords>Chemistry, Pharmacy, Research, Innovation, HealthCare, MaterialScience, CropScience</itunes:keywords>
    </item>
    <item>
      <title>December 8, 2009, Investor Conference Call - Rivaroxaban Data at the 2009 ASH Annual Meeting</title>
      <link>http://www.webvideo.bayer.com/downloads/9202/9206/11080/Bayer_CC_IR_091208_en.mp3</link>
      <description><![CDATA[Investor Conference Call: Data for Rivaroxaban have been presented at the 2009 ASH Annual Meeting. Presentation followed by a discussion.]]></description>
      <pubDate>Tue, 8 Dec 2009 11:00:00 GMT</pubDate>
      <author>bayermaildesk@bayermail.com (Bayer AG, Leverkusen, Germany)</author>
      <guid>http://www.webvideo.bayer.com/downloads/9202/9206/11080/Bayer_CC_IR_091208_en.mp3</guid>
      <category>Business</category>
      <enclosure url="http://www.webvideo.bayer.com/downloads/9202/9206/11080/Bayer_CC_IR_091208_en.mp3" length="32027175" type="audio/mpeg" />
      <itunes:author>Bayer AG, Leverkusen, Germany</itunes:author>
      <itunes:subtitle><![CDATA[]]></itunes:subtitle>
      <itunes:summary><![CDATA[Investor Conference Call: Data for Rivaroxaban have been presented at the 2009 ASH Annual Meeting. Presentation followed by a discussion.]]></itunes:summary>
      <itunes:duration>66:39</itunes:duration>
      <itunes:image href="http://www.webvideo.bayer.com" />
      <itunes:keywords>
      </itunes:keywords>
    </item>
    <item>
      <title>October 27, 2009, Q3 2009 Investor Conference Call</title>
      <link>http://www.webvideo.bayer.com/downloads/9202/9206/10942/Bayer_CC_IR_091027.mp3</link>
      <description><![CDATA[Werner Wenning, CEO of Bayer AG, at the Q3 2009 Investor Conference Call. Followed by a discussion.]]></description>
      <pubDate>Tue, 27 Oct 2009 11:00:00 GMT</pubDate>
      <author>bayermaildesk@bayermail.com (Bayer AG, Leverkusen, Germany)</author>
      <guid>http://www.webvideo.bayer.com/downloads/9202/9206/10942/Bayer_CC_IR_091027.mp3</guid>
      <category>Business</category>
      <enclosure url="http://www.webvideo.bayer.com/downloads/9202/9206/10942/Bayer_CC_IR_091027.mp3" length="35433088" type="audio/mpeg" />
      <itunes:author>Bayer AG, Leverkusen, Germany</itunes:author>
      <itunes:subtitle><![CDATA[]]></itunes:subtitle>
      <itunes:summary><![CDATA[Werner Wenning, CEO of Bayer AG, at the Q3 2009 Investor Conference Call. Followed by a discussion.]]></itunes:summary>
      <itunes:duration>73:48</itunes:duration>
      <itunes:image href="http://www.webvideo.bayer.com" />
      <itunes:keywords>
      </itunes:keywords>
    </item>
    <item>
      <title>July 29, 2009, Q2 2009 Investor Conference Call</title>
      <link>http://www.webvideo.bayer.com/downloads/9202/9206/10811/Bayer_CC_IR_090729.mp3</link>
      <description><![CDATA[Werner Wenning, CEO of Bayer AG, at the Q2 2009 Investor Conference Call. Followed by a discussion.]]></description>
      <pubDate>Wed, 29 Jul 2009 11:00:00 GMT</pubDate>
      <author>bayermaildesk@bayermail.com (Bayer AG, Leverkusen, Germany)</author>
      <guid>http://www.webvideo.bayer.com/downloads/9202/9206/10811/Bayer_CC_IR_090729.mp3</guid>
      <category>Business</category>
      <enclosure url="http://www.webvideo.bayer.com/downloads/9202/9206/10811/Bayer_CC_IR_090729.mp3" length="42113344" type="audio/mpeg" />
      <itunes:author>Bayer AG, Leverkusen, Germany</itunes:author>
      <itunes:subtitle><![CDATA[]]></itunes:subtitle>
      <itunes:summary><![CDATA[Werner Wenning, CEO of Bayer AG, at the Q2 2009 Investor Conference Call. Followed by a discussion.]]></itunes:summary>
      <itunes:duration>87:43</itunes:duration>
      <itunes:image href="http://www.webvideo.bayer.com" />
      <itunes:keywords>
      </itunes:keywords>
    </item>
    <item>
      <title>Investor Conference Call - Review of Riociguat phase II data</title>
      <link>http://www.webvideo.bayer.com/downloads/9202/9206/10664/Bayer_CC_IR_090519_1.mp3</link>
      <description><![CDATA[Investor Conference Call: Data for Riociguat have been presented at the ATS 2009 International Conference. Presentation followed by a discussion.]]></description>
      <pubDate>Tue, 19 May 2009 11:00:00 GMT</pubDate>
      <author>bayermaildesk@bayermail.com (Bayer AG, Leverkusen, Germany)</author>
      <guid>http://www.webvideo.bayer.com/downloads/9202/9206/10664/Bayer_CC_IR_090519_1.mp3</guid>
      <category>Business</category>
      <enclosure url="http://www.webvideo.bayer.com/downloads/9202/9206/10664/Bayer_CC_IR_090519_1.mp3" length="28316992" type="audio/mpeg" />
      <itunes:author>Bayer AG, Leverkusen, Germany</itunes:author>
      <itunes:subtitle><![CDATA[]]></itunes:subtitle>
      <itunes:summary><![CDATA[Investor Conference Call: Data for Riociguat have been presented at the ATS 2009 International Conference. Presentation followed by a discussion.]]></itunes:summary>
      <itunes:duration>58:59</itunes:duration>
      <itunes:image href="http://www.webvideo.bayer.com" />
      <itunes:keywords>
      </itunes:keywords>
    </item>
    <item>
      <title>Q1 2009 Investor Conference Call</title>
      <link>http://www.webvideo.bayer.com/downloads/9202/9206/10600/Bayer_CC_IR_090429.mp3</link>
      <description><![CDATA[Werner Wenning, CEO of Bayer AG, at the Q1 2009 Investor Conference Call. Followed by a discussion.]]></description>
      <pubDate>Wed, 29 Apr 2009 11:00:00 GMT</pubDate>
      <author>bayermaildesk@bayermail.com (Bayer AG, Leverkusen, Germany)</author>
      <guid>http://www.webvideo.bayer.com/downloads/9202/9206/10600/Bayer_CC_IR_090429.mp3</guid>
      <category>Business</category>
      <enclosure url="http://www.webvideo.bayer.com/downloads/9202/9206/10600/Bayer_CC_IR_090429.mp3" length="37569664" type="audio/mpeg" />
      <itunes:author>Bayer AG, Leverkusen, Germany</itunes:author>
      <itunes:subtitle><![CDATA[]]></itunes:subtitle>
      <itunes:summary><![CDATA[Werner Wenning, CEO of Bayer AG, at the Q1 2009 Investor Conference Call. Followed by a discussion.]]></itunes:summary>
      <itunes:duration>78:15</itunes:duration>
      <itunes:image href="http://www.webvideo.bayer.com" />
      <itunes:keywords>
      </itunes:keywords>
    </item>
    <item>
      <title>FY/Q4 2008 Investor Conference Call</title>
      <link>http://www.webvideo.bayer.com/downloads/9202/9206/10513/2009_03_03_Investor_Conference-Call-en.mp3</link>
      <description><![CDATA[Werner Wenning, CEO of Bayer AG, at the FY/Q4 2008 Investor Conference Call. Followed by a discussion.]]></description>
      <pubDate>Tue, 3 Mar 2009 11:00:00 GMT</pubDate>
      <author>bayermaildesk@bayermail.com (Bayer AG, Leverkusen, Germany)</author>
      <guid>http://www.webvideo.bayer.com/downloads/9202/9206/10513/2009_03_03_Investor_Conference-Call-en.mp3</guid>
      <category>Business</category>
      <enclosure url="http://www.webvideo.bayer.com/downloads/9202/9206/10513/2009_03_03_Investor_Conference-Call-en.mp3" length="40011796" type="audio/mpeg" />
      <itunes:author>Bayer AG, Leverkusen, Germany</itunes:author>
      <itunes:subtitle><![CDATA[]]></itunes:subtitle>
      <itunes:summary><![CDATA[Werner Wenning, CEO of Bayer AG, at the FY/Q4 2008 Investor Conference Call. Followed by a discussion.]]></itunes:summary>
      <itunes:duration>83:16</itunes:duration>
      <itunes:image href="http://www.webvideo.bayer.com" />
      <itunes:keywords>
      </itunes:keywords>
    </item>
    <item>
      <title>Investor Conference Call - rivaroxaban data at AHA's Scientific Sessions 2008</title>
      <link>http://www.webvideo.bayer.com/downloads/9202/9206/10297/Bayer_CC_IR_08111_en.mp3</link>
      <description><![CDATA[Investor Conference Call: Data for rivaroxaban presented at the American Heart Association's Scientific Sessions 2008. Presentation followed by a discussion.]]></description>
      <pubDate>Mon, 10 Nov 2008 11:00:00 GMT</pubDate>
      <author>bayermaildesk@bayermail.com (Bayer AG, Leverkusen, Germany)</author>
      <guid>http://www.webvideo.bayer.com/downloads/9202/9206/10297/Bayer_CC_IR_08111_en.mp3</guid>
      <category>Business</category>
      <enclosure url="http://www.webvideo.bayer.com/downloads/9202/9206/10297/Bayer_CC_IR_08111_en.mp3" length="25936215" type="audio/mpeg" />
      <itunes:author>Bayer AG, Leverkusen, Germany</itunes:author>
      <itunes:subtitle><![CDATA[]]></itunes:subtitle>
      <itunes:summary><![CDATA[Investor Conference Call: Data for rivaroxaban presented at the American Heart Association's Scientific Sessions 2008. Presentation followed by a discussion.]]></itunes:summary>
      <itunes:duration>54:01</itunes:duration>
      <itunes:image href="http://www.webvideo.bayer.com" />
      <itunes:keywords>
      </itunes:keywords>
    </item>
    <item>
      <title>Q3 2008 Investor Conference Call</title>
      <link>http://www.webvideo.bayer.com/downloads/9202/9206/10230/Bayer_CC_IR_081029.mp3</link>
      <description><![CDATA[Werner Wenning, CEO of Bayer AG, at the Q3 2008 Investor Conference Call. Followed by a discussion.]]></description>
      <pubDate>Wed, 29 Oct 2008 11:00:00 GMT</pubDate>
      <author>bayermaildesk@bayermail.com (Bayer AG, Leverkusen, Germany)</author>
      <guid>http://www.webvideo.bayer.com/downloads/9202/9206/10230/Bayer_CC_IR_081029.mp3</guid>
      <category>Business</category>
      <enclosure url="http://www.webvideo.bayer.com/downloads/9202/9206/10230/Bayer_CC_IR_081029.mp3" length="35424855" type="audio/mpeg" />
      <itunes:author>Bayer AG, Leverkusen, Germany</itunes:author>
      <itunes:subtitle><![CDATA[]]></itunes:subtitle>
      <itunes:summary><![CDATA[Werner Wenning, CEO of Bayer AG, at the Q3 2008 Investor Conference Call. Followed by a discussion.]]></itunes:summary>
      <itunes:duration>73:47</itunes:duration>
      <itunes:image href="http://www.webvideo.bayer.com" />
      <itunes:keywords>
      </itunes:keywords>
    </item>
    <item>
      <title>Q2 2008 Investor Conference Call</title>
      <link>http://www.webvideo.bayer.com/downloads/9202/9206/10031/Bayer_CC_IR_080730_en.mp3</link>
      <description><![CDATA[Werner Wenning, CEO of Bayer AG, at the Q2 2008 Investor Conference Call. Followed by a discussion.]]></description>
      <pubDate>Wed, 30 Jul 2008 11:00:00 GMT</pubDate>
      <author>bayermaildesk@bayermail.com (Bayer AG, Leverkusen, Germany)</author>
      <guid>http://www.webvideo.bayer.com/downloads/9202/9206/10031/Bayer_CC_IR_080730_en.mp3</guid>
      <category>Business</category>
      <enclosure url="http://www.webvideo.bayer.com/downloads/9202/9206/10031/Bayer_CC_IR_080730_en.mp3" length="45353751" type="audio/mpeg" />
      <itunes:author>Bayer AG, Leverkusen, Germany</itunes:author>
      <itunes:subtitle><![CDATA[]]></itunes:subtitle>
      <itunes:summary><![CDATA[Werner Wenning, CEO of Bayer AG, at the Q2 2008 Investor Conference Call. Followed by a discussion.]]></itunes:summary>
      <itunes:duration>94:28</itunes:duration>
      <itunes:image href="http://www.webvideo.bayer.com" />
      <itunes:keywords>
      </itunes:keywords>
    </item>
    <item>
      <title>Conference Call-Review of Rivaroxaban Data at EFORT Congress</title>
      <link>http://www.webvideo.bayer.com/downloads/9202/9206/9840/Bayer_CC_IR_080530_en.mp3</link>
      <description><![CDATA[Investor Conference Call: Data for Rivaroxaban have been presented at the 9th EFORT Congress. Presentation followed by a discussion.]]></description>
      <pubDate>Fri, 30 May 2008 11:00:00 GMT</pubDate>
      <author>bayermaildesk@bayermail.com (Bayer AG, Leverkusen, Germany)</author>
      <guid>http://www.webvideo.bayer.com/downloads/9202/9206/9840/Bayer_CC_IR_080530_en.mp3</guid>
      <category>Business</category>
      <enclosure url="http://www.webvideo.bayer.com/downloads/9202/9206/9840/Bayer_CC_IR_080530_en.mp3" length="21296727" type="audio/mpeg" />
      <itunes:author>Bayer AG, Leverkusen, Germany</itunes:author>
      <itunes:subtitle><![CDATA[]]></itunes:subtitle>
      <itunes:summary><![CDATA[Investor Conference Call: Data for Rivaroxaban have been presented at the 9th EFORT Congress. Presentation followed by a discussion.]]></itunes:summary>
      <itunes:duration>44:21</itunes:duration>
      <itunes:image href="http://www.webvideo.bayer.com" />
      <itunes:keywords>
      </itunes:keywords>
    </item>
    <item>
      <title>April 24, 2008, Q1 2008 Investor Conference Call</title>
      <link>http://www.webvideo.bayer.com/downloads/9202/9206/9732/Bayer_CC_IR_080424-en.mp3</link>
      <description><![CDATA[Werner Wenning, CEO of Bayer AG, at the Q1 2008 Investor Conference Call. Followed by a discussion.]]></description>
      <pubDate>Thu, 24 Apr 2008 11:00:00 GMT</pubDate>
      <author>bayermaildesk@bayermail.com (Bayer AG, Leverkusen, Germany)</author>
      <guid>http://www.webvideo.bayer.com/downloads/9202/9206/9732/Bayer_CC_IR_080424-en.mp3</guid>
      <category>Business</category>
      <enclosure url="http://www.webvideo.bayer.com/downloads/9202/9206/9732/Bayer_CC_IR_080424-en.mp3" length="35365911" type="audio/mpeg" />
      <itunes:author>Bayer AG, Leverkusen, Germany</itunes:author>
      <itunes:subtitle><![CDATA[]]></itunes:subtitle>
      <itunes:summary><![CDATA[Werner Wenning, CEO of Bayer AG, at the Q1 2008 Investor Conference Call. Followed by a discussion.]]></itunes:summary>
      <itunes:duration>73:40</itunes:duration>
      <itunes:image href="http://www.webvideo.bayer.com" />
      <itunes:keywords>
      </itunes:keywords>
    </item>
    <item>
      <title>FY/Q4 2007 Investor Conference Call</title>
      <link>http://www.webvideo.bayer.com/downloads/9202/9206/9521/2008_02_28_Investor_Conference-Call-en.mp3</link>
      <description><![CDATA[Werner Wenning, CEO of Bayer AG, at the FY/Q4 2007 Investor Conference Call. Followed by a discussion.]]></description>
      <pubDate>Thu, 28 Feb 2008 11:00:00 GMT</pubDate>
      <author>bayermaildesk@bayermail.com (Bayer AG, Leverkusen, Germany)</author>
      <guid>http://www.webvideo.bayer.com/downloads/9202/9206/9521/2008_02_28_Investor_Conference-Call-en.mp3</guid>
      <category>Business</category>
      <enclosure url="http://www.webvideo.bayer.com/downloads/9202/9206/9521/2008_02_28_Investor_Conference-Call-en.mp3" length="39035012" type="audio/mpeg" />
      <itunes:author>Bayer AG, Leverkusen, Germany</itunes:author>
      <itunes:subtitle><![CDATA[]]></itunes:subtitle>
      <itunes:summary><![CDATA[Werner Wenning, CEO of Bayer AG, at the FY/Q4 2007 Investor Conference Call. Followed by a discussion.]]></itunes:summary>
      <itunes:duration>81:14</itunes:duration>
      <itunes:image href="http://www.webvideo.bayer.com" />
      <itunes:keywords>
      </itunes:keywords>
    </item>
    <item>
      <title>ASH 2007 Review of Rivaroxaban Data</title>
      <link>http://www.webvideo.bayer.com/downloads/9202/9206/9404/ash_2007_investor_conference_call_en.mp3</link>
      <description><![CDATA[Investor Conference Call: ASH 2007 Review of Rivaroxaban Data.]]></description>
      <pubDate>Tue, 11 Dec 2007 11:00:00 GMT</pubDate>
      <author>bayermaildesk@bayermail.com (Bayer AG, Leverkusen, Germany)</author>
      <guid>http://www.webvideo.bayer.com/downloads/9202/9206/9404/ash_2007_investor_conference_call_en.mp3</guid>
      <category>Business</category>
      <enclosure url="http://www.webvideo.bayer.com/downloads/9202/9206/9404/ash_2007_investor_conference_call_en.mp3" length="31514112" type="audio/mpeg" />
      <itunes:author>Bayer AG, Leverkusen, Germany</itunes:author>
      <itunes:subtitle><![CDATA[]]></itunes:subtitle>
      <itunes:summary><![CDATA[Investor Conference Call: ASH 2007 Review of Rivaroxaban Data.]]></itunes:summary>
      <itunes:duration>65:39</itunes:duration>
      <itunes:image href="http://www.webvideo.bayer.com" />
      <itunes:keywords>
      </itunes:keywords>
    </item>
    <item>
      <title>Q3 2007 Investor ConferenceCall</title>
      <link>http://www.webvideo.bayer.com/downloads/9202/9206/9396/q3_2007_investor_conference_call_en.mp3</link>
      <description><![CDATA[Werner Wenning, CEO of Bayer AG, at the Q3 2007 Investor Conference Call. Followed by a discussion.]]></description>
      <pubDate>Tue, 6 Nov 2007 11:00:00 GMT</pubDate>
      <author>bayermaildesk@bayermail.com (Bayer AG, Leverkusen, Germany)</author>
      <guid>http://www.webvideo.bayer.com/downloads/9202/9206/9396/q3_2007_investor_conference_call_en.mp3</guid>
      <category>Business</category>
      <enclosure url="http://www.webvideo.bayer.com/downloads/9202/9206/9396/q3_2007_investor_conference_call_en.mp3" length="38374272" type="audio/mpeg" />
      <itunes:author>Bayer AG, Leverkusen, Germany</itunes:author>
      <itunes:subtitle><![CDATA[]]></itunes:subtitle>
      <itunes:summary><![CDATA[Werner Wenning, CEO of Bayer AG, at the Q3 2007 Investor Conference Call. Followed by a discussion.]]></itunes:summary>
      <itunes:duration>79:56</itunes:duration>
      <itunes:image href="http://www.webvideo.bayer.com" />
      <itunes:keywords>
      </itunes:keywords>
    </item>
    <item>
      <title>Q2 2007 Investor ConferenceCall</title>
      <link>http://www.webvideo.bayer.com/downloads/9202/9206/9390/q2_2007_investor_conference_call_en.mp3</link>
      <description><![CDATA[Werner Wenning, CEO of Bayer AG, at the Q2 2007 Investor Conference Call. Followed by a discussion.]]></description>
      <pubDate>Tue, 7 Aug 2007 11:00:00 GMT</pubDate>
      <author>bayermaildesk@bayermail.com (Bayer AG, Leverkusen, Germany)</author>
      <guid>http://www.webvideo.bayer.com/downloads/9202/9206/9390/q2_2007_investor_conference_call_en.mp3</guid>
      <category>Business</category>
      <enclosure url="http://www.webvideo.bayer.com/downloads/9202/9206/9390/q2_2007_investor_conference_call_en.mp3" length="31329749" type="audio/mpeg" />
      <itunes:author>Bayer AG, Leverkusen, Germany</itunes:author>
      <itunes:subtitle><![CDATA[]]></itunes:subtitle>
      <itunes:summary><![CDATA[Werner Wenning, CEO of Bayer AG, at the Q2 2007 Investor Conference Call. Followed by a discussion.]]></itunes:summary>
      <itunes:duration>65:16</itunes:duration>
      <itunes:image href="http://www.webvideo.bayer.com" />
      <itunes:keywords>
      </itunes:keywords>
    </item>
    <item>
      <title>Bayer HealthCare Investor Day 2007: Speech Werner Wenning and Arthur Higgins</title>
      <link>http://www.webvideo.bayer.com/downloads/9202/9206/9368/wenning-higgins_en.mp3</link>
      <description><![CDATA[Speech of Werner Wenning, CEO of Bayer AG, and Arthur Higgins, CEO of Bayer HealthCare, at the Bayer HealthCare Investor Day 2007.]]></description>
      <pubDate>Tue, 19 Jun 2007 11:00:00 GMT</pubDate>
      <author>bayermaildesk@bayermail.com (Bayer AG, Leverkusen, Germany)</author>
      <guid>http://www.webvideo.bayer.com/downloads/9202/9206/9368/wenning-higgins_en.mp3</guid>
      <category>Business</category>
      <enclosure url="http://www.webvideo.bayer.com/downloads/9202/9206/9368/wenning-higgins_en.mp3" length="16656960" type="audio/mpeg" />
      <itunes:author>Bayer AG, Leverkusen, Germany</itunes:author>
      <itunes:subtitle><![CDATA[]]></itunes:subtitle>
      <itunes:summary><![CDATA[Speech of Werner Wenning, CEO of Bayer AG, and Arthur Higgins, CEO of Bayer HealthCare, at the Bayer HealthCare Investor Day 2007.]]></itunes:summary>
      <itunes:duration>34:42</itunes:duration>
      <itunes:image href="http://www.webvideo.bayer.com" />
      <itunes:keywords>
      </itunes:keywords>
    </item>
    <item>
      <title>Bayer HealthCare Investor Day 2007: Speech Prof. Dr. Andreas Busch</title>
      <link>http://www.webvideo.bayer.com/downloads/9202/9206/9372/busch_en.mp3</link>
      <description><![CDATA[Speech of Prof. Dr. Andreas Busch, Head of Global Drug Discovery at Bayer Schering Pharma, at the Bayer HealthCare Investor Day 2007.]]></description>
      <pubDate>Tue, 19 Jun 2007 11:00:00 GMT</pubDate>
      <author>bayermaildesk@bayermail.com (Bayer AG, Leverkusen, Germany)</author>
      <guid>http://www.webvideo.bayer.com/downloads/9202/9206/9372/busch_en.mp3</guid>
      <category>Business</category>
      <enclosure url="http://www.webvideo.bayer.com/downloads/9202/9206/9372/busch_en.mp3" length="10439424" type="audio/mpeg" />
      <itunes:author>Bayer AG, Leverkusen, Germany</itunes:author>
      <itunes:subtitle><![CDATA[]]></itunes:subtitle>
      <itunes:summary><![CDATA[Speech of Prof. Dr. Andreas Busch, Head of Global Drug Discovery at Bayer Schering Pharma, at the Bayer HealthCare Investor Day 2007.]]></itunes:summary>
      <itunes:duration>21:45</itunes:duration>
      <itunes:image href="http://www.webvideo.bayer.com" />
      <itunes:keywords>
      </itunes:keywords>
    </item>
    <item>
      <title>Bayer HealthCare Investor Day 2007: Speech Dr. Kemal Malik</title>
      <link>http://www.webvideo.bayer.com/downloads/9202/9206/9374/malik_en.mp3</link>
      <description><![CDATA[Speech of Dr. Kemal Malik, Head of Global Development at Bayer Schering Pharma, at the Bayer HealthCare Investor Day 2007.]]></description>
      <pubDate>Tue, 19 Jun 2007 11:00:00 GMT</pubDate>
      <author>bayermaildesk@bayermail.com (Bayer AG, Leverkusen, Germany)</author>
      <guid>http://www.webvideo.bayer.com/downloads/9202/9206/9374/malik_en.mp3</guid>
      <category>Business</category>
      <enclosure url="http://www.webvideo.bayer.com/downloads/9202/9206/9374/malik_en.mp3" length="14671296" type="audio/mpeg" />
      <itunes:author>Bayer AG, Leverkusen, Germany</itunes:author>
      <itunes:subtitle><![CDATA[]]></itunes:subtitle>
      <itunes:summary><![CDATA[Speech of Dr. Kemal Malik, Head of Global Development at Bayer Schering Pharma, at the Bayer HealthCare Investor Day 2007.]]></itunes:summary>
      <itunes:duration>30:34</itunes:duration>
      <itunes:image href="http://www.webvideo.bayer.com" />
      <itunes:keywords>
      </itunes:keywords>
    </item>
    <item>
      <title>Bayer HealthCare Investor Day 2007: Speech Dr. Gunnar Riemann</title>
      <link>http://www.webvideo.bayer.com/downloads/9202/9206/9376/riemann_en.mp3</link>
      <description><![CDATA[Speech of Dr. Gunnar Riemann, Member of the Board of Management of Bayer Schering Pharma, at the Bayer HealthCare Investor Day 2007.]]></description>
      <pubDate>Tue, 19 Jun 2007 11:00:00 GMT</pubDate>
      <author>bayermaildesk@bayermail.com (Bayer AG, Leverkusen, Germany)</author>
      <guid>http://www.webvideo.bayer.com/downloads/9202/9206/9376/riemann_en.mp3</guid>
      <category>Business</category>
      <enclosure url="http://www.webvideo.bayer.com/downloads/9202/9206/9376/riemann_en.mp3" length="12350784" type="audio/mpeg" />
      <itunes:author>Bayer AG, Leverkusen, Germany</itunes:author>
      <itunes:subtitle><![CDATA[]]></itunes:subtitle>
      <itunes:summary><![CDATA[Speech of Dr. Gunnar Riemann, Member of the Board of Management of Bayer Schering Pharma, at the Bayer HealthCare Investor Day 2007.]]></itunes:summary>
      <itunes:duration>25:44</itunes:duration>
      <itunes:image href="http://www.webvideo.bayer.com" />
      <itunes:keywords>
      </itunes:keywords>
    </item>
    <item>
      <title>Bayer HealthCare Investor Day 2007: Speech Dr. Ulrich Koestlin</title>
      <link>http://www.webvideo.bayer.com/downloads/9202/9206/9378/koestlin_en.mp3</link>
      <description><![CDATA[Speech of Dr. Ulrich Koestlin, Member of the Board of Management of Bayer Schering Pharma, at the Bayer HealthCare Investor Day 2007.]]></description>
      <pubDate>Tue, 19 Jun 2007 11:00:00 GMT</pubDate>
      <author>bayermaildesk@bayermail.com (Bayer AG, Leverkusen, Germany)</author>
      <guid>http://www.webvideo.bayer.com/downloads/9202/9206/9378/koestlin_en.mp3</guid>
      <category>Business</category>
      <enclosure url="http://www.webvideo.bayer.com/downloads/9202/9206/9378/koestlin_en.mp3" length="9882624" type="audio/mpeg" />
      <itunes:author>Bayer AG, Leverkusen, Germany</itunes:author>
      <itunes:subtitle><![CDATA[]]></itunes:subtitle>
      <itunes:summary><![CDATA[Speech of Dr. Ulrich Koestlin, Member of the Board of Management of Bayer Schering Pharma, at the Bayer HealthCare Investor Day 2007.]]></itunes:summary>
      <itunes:duration>20:35</itunes:duration>
      <itunes:image href="http://www.webvideo.bayer.com" />
      <itunes:keywords>
      </itunes:keywords>
    </item>
    <item>
      <title>Bayer HealthCare Investor Day 2007: Speech Gary Balkema</title>
      <link>http://www.webvideo.bayer.com/downloads/9202/9206/9380/balkema_en.mp3</link>
      <description><![CDATA[Speech of Gary Balkema, President of the Consumer Care Division, at the Bayer HealthCare Investor Day 2007.]]></description>
      <pubDate>Tue, 19 Jun 2007 11:00:00 GMT</pubDate>
      <author>bayermaildesk@bayermail.com (Bayer AG, Leverkusen, Germany)</author>
      <guid>http://www.webvideo.bayer.com/downloads/9202/9206/9380/balkema_en.mp3</guid>
      <category>Business</category>
      <enclosure url="http://www.webvideo.bayer.com/downloads/9202/9206/9380/balkema_en.mp3" length="7772160" type="audio/mpeg" />
      <itunes:author>Bayer AG, Leverkusen, Germany</itunes:author>
      <itunes:subtitle><![CDATA[]]></itunes:subtitle>
      <itunes:summary><![CDATA[Speech of Gary Balkema, President of the Consumer Care Division, at the Bayer HealthCare Investor Day 2007.]]></itunes:summary>
      <itunes:duration>16:12</itunes:duration>
      <itunes:image href="http://www.webvideo.bayer.com" />
      <itunes:keywords>
      </itunes:keywords>
    </item>
    <item>
      <title>Bayer HealthCare Investor Day 2007: Speech Sandra Peterson</title>
      <link>http://www.webvideo.bayer.com/downloads/9202/9206/9382/peterson_en.mp3</link>
      <description><![CDATA[Speech of Sandra Peterson, President of the Diabetes Care Division, at the Bayer HealthCare Investor Day 2007.]]></description>
      <pubDate>Tue, 19 Jun 2007 11:00:00 GMT</pubDate>
      <author>bayermaildesk@bayermail.com (Bayer AG, Leverkusen, Germany)</author>
      <guid>http://www.webvideo.bayer.com/downloads/9202/9206/9382/peterson_en.mp3</guid>
      <category>Business</category>
      <enclosure url="http://www.webvideo.bayer.com/downloads/9202/9206/9382/peterson_en.mp3" length="10704384" type="audio/mpeg" />
      <itunes:author>Bayer AG, Leverkusen, Germany</itunes:author>
      <itunes:subtitle><![CDATA[]]></itunes:subtitle>
      <itunes:summary><![CDATA[Speech of Sandra Peterson, President of the Diabetes Care Division, at the Bayer HealthCare Investor Day 2007.]]></itunes:summary>
      <itunes:duration>22:18</itunes:duration>
      <itunes:image href="http://www.webvideo.bayer.com" />
      <itunes:keywords>
      </itunes:keywords>
    </item>
    <item>
      <title>Bayer HealthCare Investor Day 2007: Speech Lykele van der Broek</title>
      <link>http://www.webvideo.bayer.com/downloads/9202/9206/9384/vanderbroek_en.mp3</link>
      <description><![CDATA[Speech of Lykele van der Broek, Head of the Animal Health Division, at the Bayer HealthCare Investor Day 2007.]]></description>
      <pubDate>Tue, 19 Jun 2007 11:00:00 GMT</pubDate>
      <author>bayermaildesk@bayermail.com (Bayer AG, Leverkusen, Germany)</author>
      <guid>http://www.webvideo.bayer.com/downloads/9202/9206/9384/vanderbroek_en.mp3</guid>
      <category>Business</category>
      <enclosure url="http://www.webvideo.bayer.com/downloads/9202/9206/9384/vanderbroek_en.mp3" length="8193024" type="audio/mpeg" />
      <itunes:author>Bayer AG, Leverkusen, Germany</itunes:author>
      <itunes:subtitle><![CDATA[]]></itunes:subtitle>
      <itunes:summary><![CDATA[Speech of Lykele van der Broek, Head of the Animal Health Division, at the Bayer HealthCare Investor Day 2007.]]></itunes:summary>
      <itunes:duration>17:04</itunes:duration>
      <itunes:image href="http://www.webvideo.bayer.com" />
      <itunes:keywords>
      </itunes:keywords>
    </item>
    <item>
      <title>Bayer HealthCare Investor Day 2007: Discussion</title>
      <link>http://www.webvideo.bayer.com/downloads/9202/9206/9386/discussion_en.mp3</link>
      <description><![CDATA[Discussion at the Bayer HealthCare Investor Day 2007.]]></description>
      <pubDate>Tue, 19 Jun 2007 11:00:00 GMT</pubDate>
      <author>bayermaildesk@bayermail.com (Bayer AG, Leverkusen, Germany)</author>
      <guid>http://www.webvideo.bayer.com/downloads/9202/9206/9386/discussion_en.mp3</guid>
      <category>Business</category>
      <enclosure url="http://www.webvideo.bayer.com/downloads/9202/9206/9386/discussion_en.mp3" length="17509824" type="audio/mpeg" />
      <itunes:author>Bayer AG, Leverkusen, Germany</itunes:author>
      <itunes:subtitle><![CDATA[]]></itunes:subtitle>
      <itunes:summary><![CDATA[Discussion at the Bayer HealthCare Investor Day 2007.]]></itunes:summary>
      <itunes:duration>36:28</itunes:duration>
      <itunes:image href="http://www.webvideo.bayer.com" />
      <itunes:keywords>
      </itunes:keywords>
    </item>
    <item>
      <title>Bayer HealthCare Investor Day 2007: Concluding Remarks by Arthur Higgins</title>
      <link>http://www.webvideo.bayer.com/downloads/9202/9206/9388/higgins_en.mp3</link>
      <description><![CDATA[Concluding Remarks by Arthur Higgins, CEO of Bayer HealthCare, at the Bayer HealthCare Investor Day 2007.]]></description>
      <pubDate>Tue, 19 Jun 2007 11:00:00 GMT</pubDate>
      <author>bayermaildesk@bayermail.com (Bayer AG, Leverkusen, Germany)</author>
      <guid>http://www.webvideo.bayer.com/downloads/9202/9206/9388/higgins_en.mp3</guid>
      <category>Business</category>
      <enclosure url="http://www.webvideo.bayer.com/downloads/9202/9206/9388/higgins_en.mp3" length="2921664" type="audio/mpeg" />
      <itunes:author>Bayer AG, Leverkusen, Germany</itunes:author>
      <itunes:subtitle><![CDATA[]]></itunes:subtitle>
      <itunes:summary><![CDATA[Concluding Remarks by Arthur Higgins, CEO of Bayer HealthCare, at the Bayer HealthCare Investor Day 2007.]]></itunes:summary>
      <itunes:duration>6:05</itunes:duration>
      <itunes:image href="http://www.webvideo.bayer.com" />
      <itunes:keywords>
      </itunes:keywords>
    </item>
    <item>
      <title>Investor ConferenceCall: ASCO 2007 Review of Nexavar Data</title>
      <link>http://www.webvideo.bayer.com/downloads/9202/9206/9366/investor_conference_call_en.mp3</link>
      <description><![CDATA[Arthur J. Higgins, CEO of Bayer HealthCare, and Dr. Kemal Malik, Head of Global Development at Bayer Schering Pharma, at the Investor Conference Call. Followed by a discussion.]]></description>
      <pubDate>Mon, 4 Jun 2007 11:00:00 GMT</pubDate>
      <author>bayermaildesk@bayermail.com (Bayer AG, Leverkusen, Germany)</author>
      <guid>http://www.webvideo.bayer.com/downloads/9202/9206/9366/investor_conference_call_en.mp3</guid>
      <category>Business</category>
      <enclosure url="http://www.webvideo.bayer.com/downloads/9202/9206/9366/investor_conference_call_en.mp3" length="14849280" type="audio/mpeg" />
      <itunes:author>Bayer AG, Leverkusen, Germany</itunes:author>
      <itunes:subtitle><![CDATA[]]></itunes:subtitle>
      <itunes:summary><![CDATA[Arthur J. Higgins, CEO of Bayer HealthCare, and Dr. Kemal Malik, Head of Global Development at Bayer Schering Pharma, at the Investor Conference Call. Followed by a discussion.]]></itunes:summary>
      <itunes:duration>31:37</itunes:duration>
      <itunes:image href="http://www.webvideo.bayer.com" />
      <itunes:keywords>
      </itunes:keywords>
    </item>
    <item>
      <title>Q1 2007 Investor ConferenceCall</title>
      <link>http://www.webvideo.bayer.com/downloads/9202/9206/9362/q1_2007_investor_conference_call_en.mp3</link>
      <description><![CDATA[Werner Wenning, CEO of Bayer AG, at the Q1 2007 Investor Conference Call. Followed by a discussion.]]></description>
      <pubDate>Tue, 8 May 2007 11:00:00 GMT</pubDate>
      <author>bayermaildesk@bayermail.com (Bayer AG, Leverkusen, Germany)</author>
      <guid>http://www.webvideo.bayer.com/downloads/9202/9206/9362/q1_2007_investor_conference_call_en.mp3</guid>
      <category>Business</category>
      <enclosure url="http://www.webvideo.bayer.com/downloads/9202/9206/9362/q1_2007_investor_conference_call_en.mp3" length="29562671" type="audio/mpeg" />
      <itunes:author>Bayer AG, Leverkusen, Germany</itunes:author>
      <itunes:subtitle><![CDATA[]]></itunes:subtitle>
      <itunes:summary><![CDATA[Werner Wenning, CEO of Bayer AG, at the Q1 2007 Investor Conference Call. Followed by a discussion.]]></itunes:summary>
      <itunes:duration>61:35</itunes:duration>
      <itunes:image href="http://www.webvideo.bayer.com" />
      <itunes:keywords>
      </itunes:keywords>
    </item>
    <item>
      <title>FY/Q4 2006 Investor Conference Call</title>
      <link>http://www.webvideo.bayer.com/downloads/9202/9206/9354/fy_q4_2006_investor_conference_call_en.mp3</link>
      <description><![CDATA[Werner Wenning, CEO of Bayer AG, at the FY/Q4 2006 Investor Conference Call. Followed by a discussion.]]></description>
      <pubDate>Thu, 15 Mar 2007 11:00:00 GMT</pubDate>
      <author>bayermaildesk@bayermail.com (Bayer AG, Leverkusen, Germany)</author>
      <guid>http://www.webvideo.bayer.com/downloads/9202/9206/9354/fy_q4_2006_investor_conference_call_en.mp3</guid>
      <category>Business</category>
      <enclosure url="http://www.webvideo.bayer.com/downloads/9202/9206/9354/fy_q4_2006_investor_conference_call_en.mp3" length="16610119" type="audio/mpeg" />
      <itunes:author>Bayer AG, Leverkusen, Germany</itunes:author>
      <itunes:subtitle><![CDATA[]]></itunes:subtitle>
      <itunes:summary><![CDATA[Werner Wenning, CEO of Bayer AG, at the FY/Q4 2006 Investor Conference Call. Followed by a discussion.]]></itunes:summary>
      <itunes:duration>12:14</itunes:duration>
      <itunes:image href="http://www.webvideo.bayer.com" />
      <itunes:keywords>
      </itunes:keywords>
    </item>
    <item>
      <title>Investor ConferenceCall: Update on the Nexavar Melanoma Program</title>
      <link>http://www.webvideo.bayer.com/downloads/9202/9206/9346/nexavar_melanoma_program_en.mp3</link>
      <description><![CDATA[Investor ConferenceCall: Update on the Nexavar Melanoma Program]]></description>
      <pubDate>Mon, 4 Dec 2006 11:00:00 GMT</pubDate>
      <author>bayermaildesk@bayermail.com (Bayer AG, Leverkusen, Germany)</author>
      <guid>http://www.webvideo.bayer.com/downloads/9202/9206/9346/nexavar_melanoma_program_en.mp3</guid>
      <category>Business</category>
      <enclosure url="http://www.webvideo.bayer.com/downloads/9202/9206/9346/nexavar_melanoma_program_en.mp3" length="2875968" type="audio/mpeg" />
      <itunes:author>Bayer AG, Leverkusen, Germany</itunes:author>
      <itunes:subtitle><![CDATA[]]></itunes:subtitle>
      <itunes:summary><![CDATA[Investor ConferenceCall: Update on the Nexavar Melanoma Program]]></itunes:summary>
      <itunes:duration>23:57</itunes:duration>
      <itunes:image href="http://www.webvideo.bayer.com" />
      <itunes:keywords>
      </itunes:keywords>
    </item>
    <item>
      <title>Q3 2006 Investor ConferenceCall: Speech by Werner Wenning</title>
      <link>http://www.webvideo.bayer.com/downloads/9202/9206/9342/wenning_en.mp3</link>
      <description><![CDATA[Werner Wenning: Q3 2006 Results]]></description>
      <pubDate>Mon, 27 Nov 2006 11:00:00 GMT</pubDate>
      <author>bayermaildesk@bayermail.com (Bayer AG, Leverkusen, Germany)</author>
      <guid>http://www.webvideo.bayer.com/downloads/9202/9206/9342/wenning_en.mp3</guid>
      <category>Business</category>
      <enclosure url="http://www.webvideo.bayer.com/downloads/9202/9206/9342/wenning_en.mp3" length="6347964" type="audio/mpeg" />
      <itunes:author>Bayer AG, Leverkusen, Germany</itunes:author>
      <itunes:subtitle><![CDATA[]]></itunes:subtitle>
      <itunes:summary><![CDATA[Werner Wenning: Q3 2006 Results]]></itunes:summary>
      <itunes:duration>26:26</itunes:duration>
      <itunes:image href="http://www.webvideo.bayer.com" />
      <itunes:keywords>
      </itunes:keywords>
    </item>
    <item>
      <title>Q3 2006 Investor ConferenceCall: Discussion</title>
      <link>http://www.webvideo.bayer.com/downloads/9202/9206/9344/discussion_en.mp3</link>
      <description><![CDATA[Q3 2006 Investor ConferenceCall: Discussion]]></description>
      <pubDate>Mon, 27 Nov 2006 11:00:00 GMT</pubDate>
      <author>bayermaildesk@bayermail.com (Bayer AG, Leverkusen, Germany)</author>
      <guid>http://www.webvideo.bayer.com/downloads/9202/9206/9344/discussion_en.mp3</guid>
      <category>Business</category>
      <enclosure url="http://www.webvideo.bayer.com/downloads/9202/9206/9344/discussion_en.mp3" length="11156480" type="audio/mpeg" />
      <itunes:author>Bayer AG, Leverkusen, Germany</itunes:author>
      <itunes:subtitle><![CDATA[]]></itunes:subtitle>
      <itunes:summary><![CDATA[Q3 2006 Investor ConferenceCall: Discussion]]></itunes:summary>
      <itunes:duration>46:29</itunes:duration>
      <itunes:image href="http://www.webvideo.bayer.com" />
      <itunes:keywords>
      </itunes:keywords>
    </item>
  </channel>
</rss>